Genmab A/S
GMAB
|
$28.72
1.38%
1.36%
360K
|
Health Technology
(0.0% 1d) (-3.1% 1m) (-29.9% 1y) (0.0% 2d) (0.0% 3d) (-3.1% 7d) (4.74% volume)
Earnings Calendar:
Market Cap: $ 18,990,515,261
http://www.genmab.com
Sec Filling | Patents | 548 employees
Genmab A/S operates as an international biotechnology company. The firm develops human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline include daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma; teprotumumab-trbw marketed as TEPEZZA for the treatment of thyroid eye disease; and ofatumumab, marketed as Arzerra for the treatment of certain indications of chronic lymphocytic leukemia. The company was founded by Donald Lee Drakeman, Florian Schonharting, and Jan G. J. van de Winkel in 1999 and is headquartered in Copenhagen, Denmark.
eye diseases cancer eye antibody leukemia treatment
add to watch list Paper trade email alert is off
Press-releases
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2024
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: 4.94%
H: 0.0%
C: -3.66%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -1.29%
H: 1.91%
C: 1.27%
darzalex sales first for
Transactions in Connection with Share Buy-back Program Genmab
Published: 2024-04-15 (Crawled : 08:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: 1.54%
H: 0.0%
C: -4.6%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -0.98%
H: 0.0%
C: 0.0%
program
Transactions in Connection with Share Buy-back Program
Published: 2024-04-08 (Crawled : 10:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: -0.16%
H: 3.73%
C: -0.3%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: 0.07%
H: 0.37%
C: 0.13%
program
Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio
Published: 2024-04-03 (Crawled : 06:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: -1.12%
H: 0.58%
C: -1.34%
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: 0.26%
H: 1.45%
C: 0.05%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -2.04%
H: 1.12%
C: -0.17%
acquisition
Transactions in Connection with Share Buy-back Program
Published: 2024-04-02 (Crawled : 08:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: -0.66%
H: 3.74%
C: 1.95%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: 0.55%
H: 1.37%
C: 0.2%
program
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published: 2024-03-29 (Crawled : 18:00) - prnewswire.com
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
| Email alert
Add to watchlist
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
| Email alert
Add to watchlist
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
| Email alert
Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
GNMSF | $290.38 3.83% 220
|
Health Technology
| Email alert
Add to watchlist
research global leukemia therapeutics market
Transactions in Connection with Share Buy-back Program
Published: 2024-03-25 (Crawled : 13:30) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: 2.32%
H: 0.0%
C: -1.08%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: 0.03%
H: 0.57%
C: 0.17%
program
Bavarian Nordic A/S – Notice Convening Annual General Meeting
Published: 2024-03-21 (Crawled : 11:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: 0.03%
H: 3.03%
C: 1.75%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
NTLA | $21.57 1.17% 1.16% 1.4M
|
Health Technology
|
| O: 2.12%
H: 0.6%
C: -2.54%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: 1.19%
H: 0.47%
C: -0.77%
meeting
Completion of share buy-back program
Published: 2024-03-18 (Crawled : 10:00) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: -0.76%
H: 0.6%
C: -0.66%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: 0.1%
H: 0.13%
C: -0.93%
program
Genmab Announces Initiation of Share Buy-Back Program
Published: 2024-03-15 (Crawled : 12:30) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: 0.34%
H: 0.0%
C: -1.89%
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: -0.7%
H: 0.98%
C: -0.11%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -0.59%
H: 0.33%
C: -0.6%
program
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Last 48 Hours Insiders Buying
RXO P 200000 | $19.37 2.32% 0.0% 1M
|
n/a
|
23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M
|
Finance
|
22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K
|
Health Technology
|
22:30
BCDA P 2750 | $0.377 -1.4% 97K
|
Health Technology
|
22:00
RMCF | $3.67 3.38% 3.27% 11K
|
Consumer Non-Durables
|
20:10